ONCOTHERAPY SCIENCE, INC.

Highlights OncoTherapy Science, Inc.

Equities

4564

JP3202150003

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-30 EDT			5-day change	1st Jan Change
26 ^JPY	-13.33%		+18.18%	+13.04%

04-29	Poland's Tusk calls prosecutor over potential Orlen scandal	RE
04-22	OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Poland's Tusk calls prosecutor over potential Orlen scandal	04-29	RE
OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company	17-07-13	CI
Split: 500 of 1	13-09-25	FA
OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A	13-07-30	CI
Shionogi & Co. Signs Agreement with OncoTherapy Science Inc. for Cancer Peptide Vaccines	12-04-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer